Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine Cardiac Troponin I (TNNI3), N-His

Name: Recombinant Canine Cardiac Troponin I (TNNI3), N-His
SKU: AP7F391
Rating: 5 (1 reviews)

Cat. No.AP7F391

Product TypeAnimal Proteins

Size

Inquiry Now Add to Basket

Product Overview

BioVenic's Recombinant Canine Cardiac Troponin I (TNNI3), N-His is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 27.6 kDa. The purity is>97% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.

Specifications

Type Recombinant Protein

Species Canine

Expression System E.coli

Purity >97% (SDS-PAGE)

Endotoxin <1 EU/μg (LAL)

Predicted Molecular Weight 27.6 kDa

Molecular Weight 32 kDa

Physical State Lyophilized

Formulation 20 mM Tris, 150 mM NaCl Buffer(pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01% SKL, 5% Trehalose, Proclin300)

Target Information

Troponin I3 cardiac type is encoded by the TNNI3 gene in dogs. It is a member of the cardiomyocyte-related genes.

Protein Canine Cardiac Troponin I (TNNI3)

Protein Synonym troponin I3 cardiac type, troponin I cardiac muscle, cardiac troponin I

Gene ID 403566

UniProt ID Q8MKD5

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 20 mM Tris, 150 mM NaCl (pH 8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex. Aliquote the reconstituted solution to minimise freeze-thaw cycles.

References

Markby, G. R. et al. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel. BMC Veterinary Research. 2020, 16: 350.